Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 7926452, 9 pages
https://doi.org/10.1155/2018/7926452
Research Article

“Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018”: Antihyperglycemic Activity of Hamelia patens Jacq. Extracts

1Centro de Investigación en Biotecnología Aplicada del Instituto Politécnico Nacional, Tlaxcala, Mexico
2Escuela Nacional de Medicina y Homeopatía del Instituto Politécnico Nacional, Ciudad de México, Mexico
3Centro de Nanociencias y Micro y Nanotecnología del Instituto Politécnico Nacional, Ciudad de México, Mexico
4Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, Unidad Sinaloa del Instituto Politécnico Nacional, Sinaloa, Mexico

Correspondence should be addressed to Fabiola E. Jiménez-Montejo; xm.npi@mzenemijef

Received 9 April 2018; Revised 21 June 2018; Accepted 31 July 2018; Published 27 August 2018

Academic Editor: Akhilesh K. Tamrakar

Copyright © 2018 Catalina Rugerio-Escalona et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. A. Matough, S. B. Budin, Z. A. Hamid, N. Alwahaibi, and J. Mohamed, “The role of oxidative stress and antioxidants in diabetic complications,” SQU Medical Journal, vol. 12, no. 1, pp. 5–18, 2012. View at Google Scholar
  2. A. W. Indrianingsih, S. Tachibana, R. T. Dewi, and K. Itoh, “Antioxidant and α-glucosidase inhibitor activities of natural compounds isolated from Quercus gilva Blume leaves,” Asian Pacific Journal of Tropical Biomedicine, vol. 5, no. 9, pp. 748–755, 2015. View at Google Scholar · View at Scopus
  3. M. Gondi and U. J. S. Prasada Rao, “Ethanol extract of mango (Mangifera indica L.) peel inhibits α-amylase and α-glucosidase activities, and ameliorates diabetes related biochemical parameters in streptozotocin (STZ)-induced diabetic rats,” Journal of Food Science and Technology, vol. 52, no. 12, pp. 7883–7893, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Rayar and R. Manivannan, “In-vitro alpha-amylase and alpha-glucosidase inhibition activity of umbelliferone and beta-ionone isolated from Coriandrum sativum Linn,” World Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 1, pp. 1280–1289, 2016. View at Google Scholar
  5. Atlas de la Diabetes de la FID-Octava edición, International Diabetes Federation, 2017.
  6. American Diabetes Association, “Pharmacologic Approaches to Glycemic Treatment,” Journal of Clinical and Applied Resarch and Education, vol. 40, no. 1, pp. S64–S76, 2017. View at Google Scholar
  7. J. J. Marín-Peñalver, I. Martín-Timón, C. Sevillano-Collantes, and F. J. del Cañizo-Gómez, “Update on the treatment of type 2 diabetes mellitus,” World Journal of Diabetes, vol. 7, no. 17, pp. 354–395, 2016. View at Publisher · View at Google Scholar
  8. H.-Y. Chang, M. Wallis, and E. Tiralongo, “Use of complementary and alternative medicine among people living with diabetes: literature review,” Journal of Advanced Nursing, vol. 58, no. 4, pp. 307–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. B. Medagama and R. Bandara, “The use of Complementary and Alternative Medicines (CAMs) in the treatment of diabetes mellitus: Is continued use safe and effective?” Nutrition Journal, vol. 13, no. 1, 2014. View at Google Scholar · View at Scopus
  10. B. Baharvand-Ahmadi, M. Bahmani, P. Tajeddini, N. Naghdi, and M. Rafieian-Kopaei, “An ethno-medicinal study of medicinal plants used for the treatment of diabetes,” Journal of Nephropathology, vol. 5, no. 1, pp. 44–50, 2016. View at Google Scholar · View at Scopus
  11. S. Verma, M. Gupta, H. Popli, and G. Aggarwal, “Diabetes mellitus treatment using herbal drugs,” International Journal of Phytomedicine, vol. 10, no. 1, pp. 1–10, 2018. View at Publisher · View at Google Scholar
  12. B. Ovalle-Magallanes, O. N. Medina-Campos, J. Pedraza-Chaverri, and R. Mata, “Hypoglycemic and antihyperglycemic effects of phytopreparations and limonoids from Swietenia humilis,” Phytochemistry, vol. 110, pp. 111–119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Singh and M. Vyas, “Comparative in-vitro biological study of aerial parts of plant Hamelia patens,” International Journal of Pharmaceutical Sciences and Research, vol. 7, no. 4, pp. 1793–1808, 2016. View at Google Scholar · View at Scopus
  14. F. Ruiz-Terán, A. Medrano-Martínez, and A. Navarro-Ocaña, “Antioxidant and free radical scavenging activities of plant extracts used in traditional medicine in Mexico,” African Journal of Biotechnology, vol. 7, no. 12, pp. 1886–1893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Sosa, M. J. Balick, R. Arvigo et al., “Screening of the topical anti-inflammatory activity of some Central American plants,” Journal of Ethnopharmacology, vol. 81, no. 2, pp. 211–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Camporese, M. J. Balick, R. Arvigo et al., “Screening of anti-bacterial activity of medicinal plants from Belize (Central America),” Journal of Ethnopharmacology, vol. 87, no. 1, pp. 103–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Mena-Rejon, E. Caamal-Fuentes, Z. Cantillo-Ciau, R. Cedillo-Rivera, J. Flores-Guido, and R. Moo-Puc, “In vitro cytotoxic activity of nine plants used in Mayan traditional medicine,” Journal of Ethnopharmacology, vol. 121, no. 3, pp. 462–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Jiménez-Suárez, A. Nieto-Camacho, M. Jiménez-Estrada, and B. Alvarado Sánchez, “Anti-inflammatory, free radical scavenging and alpha-glucosidase inhibitory activities of Hamelia patens and its chemical constituents,” Pharmaceutical Biology, vol. 54, no. 9, pp. 1822–1830, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Andrade-Cetto, S. Escandón-Rivera, and V. Garcia-Luna, “Hypoglycemic effect of Hamelia patens Jacq., aerial part in STZ-NA-induced diabetic rats,” Pharmacologyonline, vol. 3, pp. 65–69b, 2015. View at Google Scholar · View at Scopus
  20. A. Ahmad, A. Pandurangan, N. Singh, and P. Ananad, “A mini review on chemistry and biology of Hamelia Patens (Rubiaceae),” Pharmacognosy Journal, vol. 4, no. 29, pp. 1–4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Bano, S. Santra, and E. Menghani, “Hamelia patens a potential plant from Rubiaceae family: A review,” International Journal of Scientific & Engineering Research, vol. 6, no. 12, pp. 960–973, 2015. View at Google Scholar
  22. E. C. Cruz and A. Andrade-Cetto, “Ethnopharmacological field study of the plants used to treat type 2 diabetes among the Cakchiquels in Guatemala,” Journal of Ethnopharmacology, vol. 159, pp. 238–244, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Sampietro, M. A. Sgariglia, J. R. Soberón, E. N. Quiroga, and M. A. Vattuone, “Colorimetric reactions,” in Isolation, Identification and Characterization of Allelochemicals/Natural Products, chapter 4, pp. 78–82, 2009. View at Google Scholar
  24. H. P. S. Makkar and K. Becker, “Vanillin-HCl method for condensed tannins: effect of organic solvents used for extraction of tannins,” Journal of Chemical Ecology, vol. 19, no. 4, pp. 613–621, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. B. A. Cevallos-Casals and L. Cisneros-Zevallos, “Stoichiometric and kinetic studies of phenolic antioxidants from Andean purple corn and red-fleshed sweetpotato,” Journal of Agricultural and Food Chemistry, vol. 51, no. 11, pp. 3313–3319, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Salehi, B. Asghari, M. A. Esmaeili, H. Dehghan, and I. Ghazi, “α-Glucosidase and α-amylase inhibitory effect and antioxidant of ten plant extracts traditionally used in Iran for diabetes,” Journal of Medicinal Plants Research, vol. 7, no. 6, pp. 257–266, 2013. View at Google Scholar
  27. OECD/OCDE 423, OECD Guideline for testing of chemicals, Acute Oral Toxicity – Acute Toxic Class Method, Environment Directorate Organisation for Economic Co-Operation and Development, Paris, France, 2001.
  28. B. L. Furman, “Streptozotocin-induced diabetic models in mice and rats,” Current Protocols in Pharmacology, vol. 70, pp. 5.47.1–5.47.20, 2015. View at Google Scholar
  29. I. J. Flores-Sanchez and A. C. Ramos-Valdivia, “A review from patents inspired by two plant genera: Uncaria and Hamelia,” Phytochemistry Reviews, vol. 16, no. 4, pp. 693–723, 2017. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Vinayagam and B. Xu, “Antidiabetic properties of dietary flavonoids: A cellular mechanism review,” Journal of Nutrition and Metabolism, vol. 12, no. 60, pp. 1–20, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Marella, “Flavonoids-The most potent poly-phenols as antidiabetic agents: an overview,” Modern Approaches in Drug Designing, vol. 1, no. 3, pp. 2–5, 2017. View at Google Scholar
  32. A. Ullah, A. Khan, and I. Khan, “Diabetes mellitus and oxidative stress-A concise review,” Saudi Pharmaceutical Journal, vol. 24, pp. 547–553, 2016. View at Google Scholar
  33. D. Shasha, C. Magogo, and P. Dzomba, “Reversed phase HPLC-UV Quantitation of BHA, BHT and TBHQ in food items sold in bindura supermarkets, Zimbabwe,” International Research Journal of Pure & Applied Chemistry, vol. 4, no. 5, pp. 578–584, 2014. View at Google Scholar
  34. M. Vessal, M. Hemmati, and M. Vasei, “Antidiabetic effects of quercetin in streptozocin-induced diabetic rats,” Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 135, no. 3, pp. 357–364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. P.-C. Hsieh, G.-J. Huang, Y.-L. Ho et al., “Activities of antioxidants, α-glucosidase inhibitors and aldose reductase inhibitors of the aqueous extracts of four Flemingia species in Taiwan,” Botanical Studies, vol. 51, no. 3, pp. 293–302, 2010. View at Google Scholar · View at Scopus
  36. W. Kang, Y. Song, and X. Gu, “α-glucosidase inhibitory in vitro and antidiabetic activity in vivo of Osmanthus fragrans,” Journal of Medicinal Plants Research, vol. 6, no. 14, pp. 2850–2856, 2012. View at Publisher · View at Google Scholar
  37. N. Zahratunnisa, B. Elya, and A. Noviani, “Inhibition of Alpha-glucosidase and antioxidant test of stem bark extracts of Garcinia fruticosa Lauterb,” Pharmacognosy Journal, vol. 9, no. 2, pp. 273–275, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. J. E. Wong, C. Rubio, A. Reyes, C. N. Aguilar, and M. L. Carrillo, “Phenolic content and antibacterial activity of extracts of Hamelia patens obtained by different extraction methods,” Brazilian Journal of Microbiology, vol. 49, no. 3, pp. 656–661, 2017. View at Google Scholar
  39. G. Oboh, O. M. Agunloye, S. A. Adefegha, A. J. Akinyemi, and A. O. Ademiluyi, “Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): a comparative study,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 26, no. 2, pp. 165–170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. S.-Y. Chiou, J.-M. Sung, P.-W. Huang, and S.-D. Lin, “Antioxidant, Antidiabetic, and Antihypertensive Properties of Echinacea purpurea Flower Extract and Caffeic Acid Derivatives Using in Vitro Models,” Journal of Medicinal Food, vol. 20, no. 2, pp. 171–179, 2017. View at Publisher · View at Google Scholar · View at Scopus
  41. C.-M. Ma, M. Hattori, M. Daneshtalab, and L. Wang, “Chlorogenic acid derivatives with alkyl chains of different lengths and orientations: Potent α-glucosidase inhibitors,” Journal of Medicinal Chemistry, vol. 51, no. 19, pp. 6188–6194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Tan, Q. Wang, C. Luo, S. Chen, Q. Li, and P. Li, “Yeast α-glucosidase inhibitory phenolic compounds isolated from Gynura medica leaf,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 2551–2558, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. I. Suárez, B. Diaz, S. Tillett, E. Valdivieso, and R. S. Compagnone, “Leishmanicidal activity of alkaloids from Hamelia patens,” Ciencia, vol. 16, no. 2, pp. 148–155, 2008. View at Google Scholar
  44. C. Gutiérrez-Rodelo, A. Roura-Guiberna, and J. A. Olivares-Reyes, “Mecanismos moleculares de la resistencia a la insulina: una actualización,” Gaceta Médica de México, vol. 153, pp. 215–228, 2017. View at Google Scholar
  45. J. Rojas, V. Berm, E. Leal, V. Bermúdez et al., “Insulinoresistencia e hiperinsulinemia como factores de riesgo para enfermedad cardivascular,” Revista Latinoamericana de Hipertensión, vol. 2, no. 6, pp. 179–190, 2007. View at Google Scholar
  46. S. A. Bamanikar, A. A. Bamanikar, and A. Arora, “Study of serum urea and creatinine in diabetic and non-diabetic patients in a tertiary teaching hospital,” The Journal of Medical Research, vol. 2, no. 1, pp. 12–15, 2016. View at Google Scholar
  47. M. Music, A. Dervisevic, E. Pepic et al., “Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus,” Medical Archives, vol. 69, no. 4, pp. 251–255, 2015. View at Publisher · View at Google Scholar
  48. S. Kazemi, S. Asgary, J. Moshtaghian et al., “Liver-protective effects of hydroalcoholic extract of Allium hirtifolium Boiss in rats with alloxan-induced diabetes mellitus,” ARYA Atherosclerosis Journal, vol. 6, no. 1, pp. 11–15, 2010. View at Google Scholar
  49. G. A. Bonneau, M. S. Castillo Rascón, R. A. Sánchez, W. R. Pedrozo, and C. Castro Olivera, “Colesterol-IDL y parámetros lipídicos en diabéticos tipo 2,” Revista Argentina de Endocrinología y Metabolismo, vol. 44, no. 4, pp. 215–222, 2007. View at Google Scholar
  50. A. Husni, D. Purwanti, and Ustadi, “Blood glucose level and lipid profile of streptozotocin-induced diabetes rats treated with sodium alginate from Sargassum crassifolium,” Journal of Biological Sciences, vol. 16, no. 3, pp. 58–64, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Palazhy and V. Viswanathan, “Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropathy,” Diabetes & Metabolism Journal, vol. 41, no. 2, pp. 128–134, 2017. View at Publisher · View at Google Scholar · View at Scopus
  52. J. J. DiNicolantonio, J. Bhutani, and J. H. O'Keefe, “Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes,” Open Heart, vol. 2, no. 1, 2015. View at Google Scholar
  53. S. Ogawa, K. Takaeuchi, and S. Ito, “Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes,” Diabetes, Obesity and Metabolism, vol. 6, no. 5, pp. 384–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Liu, S. Shan, K. Zhang, Z.-Q. Ning, X.-P. Lu, and Y.-Y. Cheng, “Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin,” Phytotherapy Research, vol. 22, no. 10, pp. 1400–1403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. E. P. Cai and J.-K. Lin, “Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells,” Journal of Agricultural and Food Chemistry, vol. 57, no. 20, pp. 9817–9827, 2009. View at Publisher · View at Google Scholar · View at Scopus